6-[3-(4-dibenzofuran-3-yl-5-methyl-2-phenyl-4,5-dihydropyrimidin-6-yl)-5-quinolin-6-ylphenyl]quinoline
C47H32N4O — CID 154950020
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-[3-(4-dibenzofuran-3-yl-5-methyl-2-phenyl-4,5-dihydropyrimidin-6-yl)-5-quinolin-6-ylphenyl]quinoline
6-[3-(4-dibenzofuran-3-yl-5-methyl-2-phenyl-4,5-dihydropyrimidin-6-yl)-5-quinolin-6-ylphenyl]quinoline (PubChem CID 154950020) has the molecular formula C47H32N4O and a molecular weight of 668.80 g/mol. Its IUPAC name is 6-[3-(4-dibenzofuran-3-yl-5-methyl-2-phenyl-4,5-dihydropyrimidin-6-yl)-5-quinolin-6-ylphenyl]quinoline.
Molecular Properties
| Compound Name | 6-[3-(4-dibenzofuran-3-yl-5-methyl-2-phenyl-4,5-dihydropyrimidin-6-yl)-5-quinolin-6-ylphenyl]quinoline |
|---|---|
| PubChem CID | 154950020 |
| Molecular Formula | C47H32N4O |
| Molecular Weight | 668.80 g/mol |
| Exact Mass | 668.26 |
| IUPAC Name | 6-[3-(4-dibenzofuran-3-yl-5-methyl-2-phenyl-4,5-dihydropyrimidin-6-yl)-5-quinolin-6-ylphenyl]quinoline |
| SMILES | CC1C(c2cc(-c3ccc4ncccc4c3)cc(-c3ccc4ncccc4c3)c2)=NC(c2ccccc2)=NC1c1ccc2c(c1)oc1ccccc12 |
| InChI | InChI=1S/C47H32N4O/c1-29-45(35-15-18-40-39-13-5-6-14-43(39)52-44(40)28-35)50-47(30-9-3-2-4-10-30)51-46(29)38-26-36(31-16-19-41-33(23-31)11-7-21-48-41)25-37(27-38)32-17-20-42-34(24-32)12-8-22-49-42/h2-29,45H,1H3 |
| InChIKey | OCURXKWJCQOYQV-UHFFFAOYSA-N |
| XLogP | 11.64 |
| TPSA | 63.64 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 52 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 668.80 |
| LogP ≤ 5 | 11.64 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 154950020 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.